Mascha Binder
Impact in
- Neurology top 0.5%
- CNS Lymphoma Diagnosis and Treatment
- Long-Term Effects of COVID-19
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 37
- Multiple Myeloma Research and Treatments 16
- Acute Myeloid Leukemia Research 11
- Oncology 40
- Cancer Immunotherapy and Biomarkers 26
- Co-authors
- Lisa Paschold (30 shared papers)Edith Willscher (21 shared papers)Christoph Schultheiß (37 shared papers)Martin Trepel (18 shared papers)Donjetë Simnica (20 shared papers)Carsten Bokemeyer (27 shared papers)Daniel Sedding (16 shared papers)Friederike Braig (8 shared papers)
- Journals
- Blood (15 papers)Leukemia (8 papers)Haematologica (8 papers)Frontiers in Oncology (5 papers)Scientific Reports (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Mascha Binder
172 papers receiving 6k citations
Mascha Binder's Hit Papers
Peers
Comparison fields: 5 of 117
- Neurology 1.5k
- Hematology 704
- Genetics 390
- Oncology 889
- Infectious Diseases 678
Countries citing papers authored by Mascha Binder
This map shows the geographic impact of Mascha Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mascha Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mascha Binder more than expected).
Fields of papers citing papers by Mascha Binder
This network shows the impact of papers produced by Mascha Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mascha Binder. The network helps show where Mascha Binder may publish in the future.
Co-authors
The 25 scholars most cited alongside Mascha Binder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 184 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial Hit paper breakdown → | 2016 | 490 |
| 2 | The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19 Hit paper breakdown → | 2022 | 321 |
| 3 | 2017 | 294 | |
| 4 | 2020 | 292 | |
| 5 | 2020 | 264 | |
| 6 | 2016 | 227 | |
| 7 | 2013 | 188 | |
| 8 | HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children Hit paper breakdown → | 2021 | 149 |
| 9 | 2016 | 139 | |
| 10 | 2021 | 139 | |
| 11 | 2016 | 130 | |
| 12 | 2018 | 129 | |
| 13 | 2022 | 120 | |
| 14 | 2021 | 115 | |
| 15 | 2017 | 103 | |
| 16 | 2006 | 101 | |
| 17 | 2018 | 101 | |
| 18 | Core-binding factor: a central player in hematopoiesis and leukemia. | 1999 | 95 |
| 19 | 2012 | 94 | |
| 20 | 2015 | 85 |
About Mascha Binder
Mascha Binder is a scholar working on Hematology, Oncology, Neurology, Genetics and Pathology and Forensic Medicine, having authored 184 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (26 papers), Lymphoma Diagnosis and Treatment (20 papers), Multiple Myeloma Research and Treatments (16 papers), Chronic Lymphocytic Leukemia Research (15 papers), CNS Lymphoma Diagnosis and Treatment (15 papers), SARS-CoV-2 and COVID-19 Research (15 papers), Acute Myeloid Leukemia Research (11 papers) and T-cell and B-cell Immunology (11 papers). The work is most often cited by research in Neurology (1.5k citations), Hematology (704 citations), Genetics (390 citations), Oncology (889 citations) and Infectious Diseases (678 citations). Mascha Binder has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Lisa Paschold, Edith Willscher, Christoph Schultheiß, Martin Trepel, Donjetë Simnica, Carsten Bokemeyer, Daniel Sedding, Friederike Braig, Magali Noval Rivas and Rebecca Porritt. Their work appears in journals such as Blood, Leukemia, Haematologica, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.